SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENTLoan and Security Agreement • September 17th, 2021 • Humacyte, Inc. • Biological products, (no disgnostic substances) • New York
This SECOND AMENDMENT to Loan and Security Agreement (this “Amendment”) is entered into as of September 17, 2021 by and among (a) SILICON VALLEY BANK, a California corporation (“SVB”), in its capacity as administrative agent and collateral agent (“Agent”), (b) SVB, as a lender, (c) SVB INNOVATION CREDIT FUND VIII, L.P., a Delaware limited partnership (“SVB Capital”), as a lender (SVB and SVB Capital and each of the other “Lenders” from time to time a party to the Loan Agreement (as defined below) are referred to herein collectively as the “Lenders” and each individually as a “Lender”), (d) HUMACYTE, INC., a Delaware corporation (f/k/a Alpha Healthcare Acquisition Corp.) (“Humacyte”), and (e) HUMACYTE GLOBAL, INC., a Delaware corporation (f/k/a Humacyte, Inc.) (together with Humacyte, each individually and collectively, jointly and severally, “Borrower”).
